Cascade Metrix (CMX) is a medical technology company working within a new paradigm in critical care. The company will introduce an Automated Multiplex Analyzer ["AutoPlexer"] that will revolutionize the bedside testing of hospitalized patients whose care and recovery is dependent on repetitive, around-the-clock measurements of critical blood parameters. This innovative and proprietary ex-vivo blood analysis system is first being applied to the automated multiplex measurement of glucose, lactate, hematocrit and ScvO2 in critically ill patients.
Latest News: CMX is pleased to announce that it has been awarded a highly competitive SBIR Phase 1 grant funding (1R43GM146498-01; "A Multiplex Analyzer for Sepsis Management"; PI: Kislaya Kunjan) from National Institute of General Medical Sciences (NIGMS). Additional details on the project are available on the RePORTER.NIH.gov Portal. In addition to this, Elevate Ventures is providing additional non-dilutive matching funds!